<div>ATS: American Thoracic Society; CDC: Centers for Disease Control; IDSA:
Infectious Disease Society of America (25).</div><div>Symptomatic relief measures were incorporated to alleviate the patient’s
presenting symptoms and improve overall comfort and well-being.
Analgesics such as acetaminophen were administered to alleviate
pleuritic chest pain and fever. Hemoptysis management involved bed rest,
maintaining airway patency, and monitoring for signs of respiratory
distress.</div><div>Given the patient’s reported weight loss and fatigue, nutritional
supplementation and dietary counseling were provided to optimize
nutritional status and support immune function during treatment.</div><div>Strict infection control measures were implemented to prevent the
transmission of Mycobacterium tuberculosis to healthcare workers and
other patients. Standard precautions, including airborne precautions,
were observed during patient care, particularly during
aerosol-generating procedures such as bronchoscopy.</div><div>The patient and their family members were provided with comprehensive
education regarding the nature of tuberculosis, the importance of
treatment adherence, potential adverse effects of medications, and
infection control measures to prevent disease transmission.</div><div>Close monitoring of the patient’s clinical response to treatment,
including resolution of symptoms, and laboratory markers of disease
activity, was performed at regular intervals. Periodic follow-up
appointments were scheduled to assess treatment adherence, monitor for
adverse effects of antitubercular medications.</div>